Micro Market Research
+1-888-502-0539
US/CAN Toll Free

You are here :   Home     Healthcare     Biotechnology     Life Sciences Research     Genomics     DNA Sequencing    

Global Restriction Endonuclease Kit Market By End User (Industrial Research & Development, Academics, Diagnostic Labs), By Geography - Analysis & Forecast to 2019

DNA is made up of nucleic acid where nucleotide subunits of nucleic acids are joined by phosphodiester bonds. Today, maximum experiment which are held on DNA, demands cleaving of these bonds. Nuclease is enzyme which is capable of cleaving these phosphodiester bonds. Restriction endonuclease is class of enzyme that is capable of cleaving DNA at or near specific recognition nucleotide sequences known as restriction sites.

Restriction enzymes are usually classified into four types on the basis of subunit composition, cleavage position, sequence specificity and cofactor requirements. There are four classes of restriction endonucleases namely types I, II, III and IV. But at molecular level there are many more types.  Restriction enzymes recognize a specific sequence of nucleotides and produce a double-stranded cut in the DNA. The recognition sequences can also be classified by the number or bases in its recognition site, usually between 4 and 8 bases. This site specificity property make it useful tool in many processes such as, as restriction fragment length polymorphism (RFLP), genomic mapping, several recombinant procedures and DNA sequencing.

The factors driving this market are increasing implementation of molecular biology techniques, R&D activities. Factors that limit this market are high cost of downstream activities and accuracy of the enzymes growth.

The market is governed by product approvals and regulatory policies.  North America and Europe are the major revenue generating regions in the RE kit market due to the presence of manufacturers and increasing R&D activities. Asia Pacific and RoW regions prove to be lucrative markets due to the increasing research projects which are government funded and increasing commercial production.

The report segments the market on basis of end-users and on the basis of geography. By end-users, market is segmented as – Industrial R&D, Academics, Diagnostic labs. The key players of this market are Agilent Technologies, Inc., Genetix Biotech Asia Pvt. Ltd., New England Biolabs, Inc., ThermoFisher Scientific, Inc., and Promega Corporation.

DNA is made up of nucleic acid where nucleotide subunits of nucleic acids are joined by phosphodiester bonds. Today, maximum experiment which are held on DNA, demands cleaving of these bonds. Nuclease is enzyme which is capable of cleaving these phosphodiester bonds. Restriction endonuclease is class of enzyme that is capable of cleaving DNA at or near specific recognition nucleotide sequences known as restriction sites.

Restriction enzymes are usually classified into four types on the basis of subunit composition, cleavage position, sequence specificity and cofactor requirements. There are four classes of restriction endonucleases namely types I, II, III and IV. But at molecular level there are many more types.  Restriction enzymes recognize a specific sequence of nucleotides and produce a double-stranded cut in the DNA. The recognition sequences can also be classified by the number or bases in its recognition site, usually between 4 and 8 bases. This site specificity property make it useful tool in many processes such as, as restriction fragment length polymorphism (RFLP), genomic mapping, several recombinant procedures and DNA sequencing.

The factors driving this market are increasing implementation of molecular biology techniques, R&D activities. Factors that limit this market are high cost of downstream activities and accuracy of the enzymes growth.

The market is governed by product approvals and regulatory policies.  North America and Europe are the major revenue generating regions in the RE kit market due to the presence of manufacturers and increasing R&D activities. Asia Pacific and RoW regions prove to be lucrative markets due to the increasing research projects which are government funded and increasing commercial production.

The report segments the market on basis of end-users and on the basis of geography. By end-users, market is segmented as – Industrial R&D, Academics, Diagnostic labs. The key players of this market are Agilent Technologies, Inc., Genetix Biotech Asia Pvt. Ltd., New England Biolabs, Inc., ThermoFisher Scientific, Inc., and Promega Corporation.

show more
Connect With Us
US/CAN : +1-888-502-0539